NCT01706796View on ClinicalTrials.gov

A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Healthy
Interventions
DRUG

PF-06273340

Oral solution, single dose, fasted

DRUG

PF-06273340

Immediate Release Tablet, single dose, fasted

DRUG

PF-06273340

Modified Release Tablet (short duration, MR1), single dose, fasted

DRUG

PF-06273340

Modified Release Tablet (long duration, MR2), single dose, fasted

DRUG

PF-06273340

Modified Release Tablet (short duration, MR1), single dose, fed

DRUG

PF-06273340

Modified Release Tablet (long duration, MR2), single dose, fed

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY